25 Jul 2019
FoamPartner receives 3M Service Award
Leverkusen (Germany) / Wolfhausen (Switzerland) / Langenthal (Switzerland), June 2019. As a manufacturer, developer, and processor, the FoamPartner Group, headquartered in Wolfhausen (Canton of Zurich, Switzerland) supplies trade and industry worldwide with foams for a wide range of applications. For many years now, FoamPartner has been a strategic supplier for the US multi-tech corporation- 3M. FoamPartner also supplies its affiliate with more than 40 different polishing and interface pads for use in the automotive branch; some for the OEM, some for sales in the aftermarket trade.
25 Jul 2019
Clariant to focus on its core high value specialty businesses
Clariant and SABIC have agreed to temporarily suspend the discussions on the intended business combination High Performance Materials (HPM), consisting of Clariant’s Additives and high value Masterbatches and parts of SABIC’s Specialties business.
25 Jul 2019
Clariant grows sales and operating cash flow in the first half year 2019
“The first half year 2019 was admittedly challenging - particularly the second quarter, which was additionally impacted by temporary negative influences and one-off occurrences. Our continuing businesses showed resilience in this difficult environment, which comforts us in our strategic decision to divest Masterbatches and Pigments,” said Hariolf Kottmann, Executive Chairman of Clariant. “Despite the uncertainties of the current economic environment, the growth profile of our continuing portfolio remains unchanged. We will continue to intensify our focus on customer experience and fast reliable customer fulfillment, enabling Clariant to realize above-market growth, higher profitability and stronger cash generation.”
24 Jul 2019
Clariant Adds Pharmaceutical Desiccant Packet Production Capability in Cuddalore, India
The Clariant Healthcare Packaging business unit is now producing desiccant packets at its plant in Cuddalore, Tamil Nadu, India. The addition expands the range of desiccant products immediately available to customers in the region and increases global capacity.
24 Jul 2019
Clariant’s Board of Directors accepted resignation of CEO Ernesto Occhiello
Clariant, a focused and innovative specialty chemical company, today announced that Ernesto Occhiello, Chief Executive Officer and Member of the Executive Committee, has decided to leave the company for personal reasons with immediate effect. The Board of Directors accepted his resignation yesterday. The Board of Directors asked Hariolf Kottmann, Chairman of the Board of Directors of Clariant, to assume his responsibilities in the interim as Executive Chairman until a successor is found.
23 Jul 2019
SABIC heads to Japan in July for next global LNP™ anniversary technical summit
A series of global technical summits being held by SABIC to mark 70 years of its LNP™ product line of engineering thermoplastic compounds and resins continues later this month, in Japan. SABIC has invited engineers and designers at ODMs and OEMs, molders and toolmakers from around the country to the World Trade Center, Tokyo, on July 23, for a series of presentations tuned to key aspects of the Japanese market, delegates will also have the opportunity to look at application-related displays, and have one-on-one meetings with company experts.
22 Jul 2019
Archroma to introduce new formaldehyde-free* low temperature curing binder for soft vibrant and durable pigment prints
Archroma, a global leader in color and specialty chemicals towards sustainable solutions, has recently launched at the ITMA exhibition its new Helizarin® LTC New liq, a formaldehyde-free* low temperature curing binder for pigment printing on all kinds of fibers.
22 Jul 2019
Clariant signs an agreement regarding the sale of its Healthcare Packaging Business
Clariant, a focused and innovative specialty chemical company, has signed an agreement with respect to the sale of its Healthcare Packaging business to a newly-formed affiliate of Arsenal Capital Partners. The total consideration of the sale amounts to approximately CHF 308 million payable at closing, which is expected in Q4 2019. The total consideration is equivalent to 13.2 times adjusted FY2018 EBITDA. The closing of the transaction is subject to customary conditions and approvals.
